Precision Biosciences.

PositionTRIANGLE BRIEFS: DURHAM

Gene-therapy researcher Precision Biosciences plans to raise as much as $154 million in an initial public offering. Precision has about 130 employees and previously raised about $300 million...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT